CSTL - Company ID 0001447362
The table below shows CASTLE BIOSCIENCES INC's income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Revenue | $344.23M | $332.07M | $219.79M | $137.04M | $94.08M | $62.65M |
| Cost of revenue | $71.03M | $60.20M | $44.98M | $32.01M | $15.82M | $9.69M |
| Gross profit | - | - | - | - | - | $52.96M |
| R&D | $51.85M | $52.04M | $53.62M | $44.90M | $29.65M | $13.26M |
CASTLE BIOSCIENCES INC reported annual revenue of $344.23M for fiscal year 2025. That is up 3.7% from $332.07M in fiscal 2024. Over the 8 fiscal years shown, annual revenue grew from $22.79M (FY 2018) to $344.23M. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| SG&A |
| $229.32M |
| $200.05M |
| $180.15M |
| $143.00M |
| $86.74M |
| $48.13M |
| Operating income | -$42.81M | $8.67M | -$67.98M | -$72.86M | -$40.08M | -$6.54M |
| Income tax | -$5.36M | $3.32M | $101.00K | -$1.77M | -$8.72M | $84.00K |
| Net income | -$24.16M | $18.25M | -$57.47M | -$67.14M | -$31.29M | -$10.28M |
| EPS (diluted) | -$0.83 | $0.62 | -$2.14 | -$2.58 | -$1.24 | -$0.54 |